Bio & Pharma
-
Bio & Pharma
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confere...
Aug 30, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Gencurix, Hitachi to cooperate on molecular diagnostics
South Korean biotech company Gencurix Inc. said on Tuesday that it will cooperate with Japan's Hitachi High-Tech Corporation to enter the Japanese ca...
Aug 29, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Volpara to supply cancer diagnostics SW to Intermountain Health
Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software devel...
Aug 21, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a com...
Aug 21, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
CHA Healthcare incorporates Singapore's SMG as subsidiary
South Korea's CHA Healthcare Co., CHA Biotech's overseas medical business affiliate incorporated Singapore's SMG as a subsidiary. CHA Healthcare anno...
Aug 19, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Bioscience sells stake in US vaccine developer Novavax
SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. f...
Aug 16, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune d...
Aug 16, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion scraps merger with Celltrion Pharm
South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&D...
Aug 16, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Lunit participates in Singapore's AI diagnostic solution project
Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that it solely participates in a chest X-ray reading workflow improvement...
Aug 14, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now availa...
Aug 13, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, a...
Aug 12, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion's Zymfentra joins US insurance-covered drug lists
South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixima...
Aug 06, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune disea...
Jul 31, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Huonslab eyes speedy anticancer drug delivery with new patent
South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a technol...
Jul 23, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Celltrion’s new plant in Songdo poised for commercial production
South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process valu...
Jul 23, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Lunit to supply AI cancer diagnostics to Qatar
Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Insi...
Jul 22, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn
South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kong...
Jul 18, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion's Remsima SC breaks 20% market share in Europe
South Korea's biopharmaceutical company Celltrion Inc. said on Wednesday that its subcutaneous autoimmune disease treatment Remsima SC has surpassed ...
Jul 17, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong wins permission for Nabota in Argentina
South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Adm...
Jul 15, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Elec invests in US bio startup Element Biosciences
Samsung Electronics Co., the world’s top memory chipmaker, said on Friday it has invested in US biotech startup Element Biosciences Inc. to exp...
Jul 12, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung to invest $52 mn in US biotech VC Flagship Pioneering
Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72 ...
Jul 11, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
PharmaResearch acquires TuringBio for digital therapeutics
PharmaResearch Co., a South Korean company specializing in regenerative medicine, announced on Wednesday that it acquired TuringBio, an AI-based digi...
Jul 10, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
GC Biopharma exports Alyglo to US
South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglobu...
Jul 09, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
Kwangdong Pharma acquires stake in Precision Bio
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company ...
Jul 03, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
LG Chem launches Synovian in China
South Korea's LG Chem Ltd. announced on Wednesday that it launched its homegrown new drug for osteoarthritis Synovian (marketed in China as Hyruan ON...
Jul 03, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Samsung’s biotech duo on a roll with $1.1 bn CMO order
Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract manu...
Jul 03, 2024 (Gmt+09:00)
2 Min read -
Bio & Pharma
Lotte Biologics targets $1.1 billion in sales with new bio plants
South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 2030...
Jul 03, 2024 (Gmt+09:00)
3 Min read -
Bio & Pharma
Daewoong, Indonesia's IPB to co-research on primate
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut Pe...
Jun 27, 2024 (Gmt+09:00)
1 Min read -
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug A...
Jun 25, 2024 (Gmt+09:00)
1 Min read
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google